liver

The role of gut microbiota imbalance in gut-liver axis dysfunction and cancer progression

Professor Maria Rescigno explores the critical role of the gut microbiota in maintaining intestinal barrier integrity and its implications for health. 

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

Fiber-rich diet and specific gut microbes may alleviate alcohol-induced liver injury

The findings of a recent study suggest that combining dietary fiber with B. acidifaciens can be a therapeutic strategy for alcoholic liver disease.

The new frontier: polyclonal antibodies in microbiome editing

Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.

Gut metabolites may help to predict infection risk after liver transplant

The findings suggest that microbial metabolites can help to predict who is at increased risk of infection after liver transplant. The results may also help to inform microbiota-targeted therapies.

Gut microbes may promote the recovery of liver function in cancer patients

The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.

Dietary intervention may change the microbiota, alleviate fatty liver disease

The findings of a recent study suggest that resistant-starch supplements can alter the gut microbiota in ways that alleviate NAFLD.

Nicotine-degrading microbes may protect against smoking-related liver disease

Scientists identified a bacterium, Bacteroides xylanisolvens, that reduced gut nicotine concentrations in mice exposed to nicotine as well as the severity of NAFLD.

Microbiota-derived ethanol may contribute to nonalcoholic fatty liver disease

The findings of a new research suggest that, in some people, microbial ethanol can contribute to the development of NAFLD.

New study demonstrates the positive outcomes of FMT in NAFLD patients

Faecal microbiota transplant appears to effectively improve both clinical parameters and bacterial balance in the liver, especially in thin individuals.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top